Chemclin Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	648.39	400.25	448.66	342.14	311.63	224.82
Trading Asset Securities	215	509	470	643	613	328.57
Cash & Short-Term Investments	863.39	909.25	918.66	985.14	924.63	553.39
Cash Growth	-2.96%	-1.02%	-6.75%	6.54%	67.08%	-5.10%
Accounts Receivable	19.33	20.31	25.29	34.06	35.13	31.28
Other Receivables	3.65	3.87	6.48	2.94	3.21	3.25
Receivables	22.97	24.18	31.77	37.01	38.34	34.52
Inventory	113.82	109.26	110.61	112.56	122.36	98.67
Other Current Assets	30.81	24.99	41.59	30.55	5.96	15.75
Total Current Assets	1,031	1,068	1,103	1,165	1,091	702.34
Property, Plant & Equipment	466.54	483.65	495.01	223.44	157.85	125.54
Goodwill	153.76	153.76	153.76	153.76	153.76	153.76
Other Intangible Assets	36.92	41.48	34.24	13.97	13.75	14.07
Long-Term Deferred Tax Assets	33.6	31.51	22.08	15.17	10.7	4.02
Long-Term Deferred Charges	49.89	54.08	12.84	19.59	3.55	7.1
Total Assets	1,772	1,832	1,821	1,591	1,431	1,007
Accounts Payable	27.55	66.63	90.24	67.75	22.03	32.04
Accrued Expenses	10.08	17.99	22.22	38.88	24.13	15.26
Current Portion of Long-Term Debt	26.7	20.19	-	-	-	-
Current Portion of Leases	-	5.25	6.66	10.9	11.39	-
Current Income Taxes Payable	8.69	4.88	9.61	16.48	9.28	6.5
Current Unearned Revenue	7.89	9.6	6.91	4.58	3.57	5.4
Other Current Liabilities	57.68	58.81	58.5	58.67	51.16	45.53
Total Current Liabilities	138.59	183.35	194.13	197.25	121.56	104.73
Long-Term Debt	190.19	200.19	196.67	-	-	-
Long-Term Leases	26.15	24.12	31.28	1.57	13.22	-
Long-Term Unearned Revenue	1	-	-	-	5	5
Long-Term Deferred Tax Liabilities	7.23	8.18	9.68	11.77	12.46	9.73
Total Liabilities	363.17	415.85	431.76	210.59	152.23	119.46
Common Stock	401.11	401.11	401	401	401	360
Additional Paid-In Capital	565.66	565.66	564.92	564.92	547.48	339.92
Retained Earnings	492.87	500.63	422.88	414.65	330.2	187.44
Treasury Stock	-51.09	-51.09	-	-	-	-
Shareholders' Equity	1,409	1,416	1,389	1,381	1,279	887.36
Total Liabilities & Equity	1,772	1,832	1,821	1,591	1,431	1,007
Total Debt	243.04	249.76	234.61	12.47	24.6	-
Net Cash (Debt)	620.35	659.5	684.05	972.67	900.03	553.39
Net Cash Growth	-3.00%	-3.59%	-29.67%	8.07%	62.64%	-5.10%
Net Cash Per Share	1.52	1.66	1.72	2.42	2.33	1.56
Filing Date Shares Outstanding	394.59	394.59	401	401	401	360
Total Common Shares Outstanding	394.59	394.59	401	401	401	360
Working Capital	892.4	884.33	908.49	968	969.74	597.61
Book Value Per Share	3.57	3.59	3.46	3.44	3.19	2.46
Tangible Book Value	1,218	1,221	1,201	1,213	1,111	719.54
Tangible Book Value Per Share	3.09	3.09	2.99	3.02	2.77	2.00
Buildings	-	306.04	-	-	-	-
Machinery	-	446.91	391.37	381.13	383.66	358.7
Construction In Progress	-	0.58	365.61	103.13	7.57	0.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.